⌘K
Loading ticker…
BIOMERICA INC · Healthcare · Pharmaceutical Products
As of 2026-06-26, BIOMERICA INC (BMRA) has a 3-month relative strength percentile of 19 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 39. The current market Stance is 47 (Neutral). Sector: Healthcare. Average daily range 6.7%, relative volume 0.44×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
Diluted EPS, last 8 quarters. Loss makers are judged by progress toward breakeven.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
19 is not yet a leadership-grade RS read, Market Stance is 47
YoY sales growth, last 8 quarters. Sales must back the earnings story.
TTM operating margin. Expansion = real operating leverage.
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
Daily range, ATR, beta, and the math for a 1-ADR stop.
BMRA is in a stage 4 downtrend, week 4. Extended from base. VCP detected: inconclusive. Distance from 50d / 200d: -19.0% / -26.9%.
No attention data for this ticker yet — it joins the daily scan once a baseline builds.
BMRA appears in 1 ETF as of Mar 2026: VXF at 0.00% weight, $31K notional.
Top 1 by value, from SEC N-PORT-P filings dated Mar 2026.
| ETF | Weight | Value |
|---|---|---|
| VXFVanguard Extended Market ETF | 0.00% | $31K |
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | BMRA Jan avg: 6.61% median: -8.10% win: 25% σ: 41.95% n: 4 2022-04-12 → 2026-05-29 | BMRA Feb avg: 13.58% median: 10.59% win: 50% σ: 29.24% n: 4 2022-04-12 → 2026-05-29 | BMRA Mar avg: -20.87% median: -26.79% win: 25% σ: 15.71% n: 4 2022-04-12 → 2026-05-29 | BMRA Apr avg: -16.64% median: -20.19% win: 20% σ: 13.63% n: 5 2022-04-12 → 2026-05-29 | BMRA May avg: -3.35% median: -2.58% win: 40% σ: 10.22% n: 5 2022-04-12 → 2026-05-29 | BMRA Jun avg: -9.70% median: -9.08% win: 25% σ: 13.28% n: 4 2022-04-12 → 2026-05-29 (current) | BMRA Jul avg: -7.33% median: -3.55% win: 25% σ: 11.98% n: 4 2022-04-12 → 2026-05-29 | BMRA Aug avg: 13.58% median: 12.38% win: 50% σ: 19.51% n: 4 2022-04-12 → 2026-05-29 | BMRA Sep avg: -14.23% median: -17.57% win: 25% σ: 19.42% n: 4 2022-04-12 → 2026-05-29 | BMRA Oct avg: 2.44% median: 6.07% win: 50% σ: 14.39% n: 4 2022-04-12 → 2026-05-29 | BMRA Nov avg: -2.42% median: -0.20% win: 50% σ: 9.74% n: 4 2022-04-12 → 2026-05-29 | BMRA Dec avg: 3.51% median: 1.30% win: 50% σ: 23.91% n: 4 2022-04-12 → 2026-05-29 |